US Stock MarketDetailed Quotes

COR Cencora

Watchlist
  • 236.090
  • -0.100-0.04%
Close Jan 13 16:00 ET
  • 236.090
  • 0.0000.00%
Post 20:01 ET
45.63BMarket Cap31.35P/E (TTM)

About Cencora Company

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Company Profile

SymbolCOR
Company NameCencora
Listing DateApr 4, 1995
Founded1947
CEOMr. Robert P. Mauch
MarketNYSE
Employees46000
Fiscal Year Ends09-30
Address1 West First Avenue
CityConshohocken
ProvincePennsylvania
CountryUnited States of America
Zip Code19428-1800
Phone1-610-727-7000

Company Executives

  • Name
  • Position
  • Salary
  • Robert P. Mauch
  • Director, President and Chief Executive Officer
  • 7.70M
  • James F. Cleary, Jr
  • Executive Vice President and Chief Financial Officer
  • 5.45M
  • Elizabeth S. Campbell
  • Executive Vice President and Chief Legal Officer
  • 4.03M
  • Silvana Battaglia
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Lazarus Krikorian
  • Senior Vice President and Chief Accounting Officer
  • --
  • Steven H. Collis
  • Executive Chairman of the Board
  • 17.51M
  • Ornella Barra
  • Director
  • --
  • Werner Baumann
  • Independent Director
  • --
  • Dennis M. Nally
  • Independent Director
  • 375.36K
  • Lauren M. Tyler
  • Independent Director
  • --
  • Frank K. Clyburn, Jr
  • Independent Director
  • --
  • Kathleen W. Hyle
  • Independent Director
  • 320.10K
  • Richard W. Gochnauer
  • Independent Director
  • 300.10K
  • Lon R. Greenberg
  • Independent Director
  • 332.60K
  • Dermot Mark Durcan
  • Lead Independent Director
  • 380.05K
  • Dr. Redonda G. Miller, M.B.A.
  • Independent Director
  • 311.82K
  • Dr. Lorence H. Kim, M.D.
  • Independent Director
  • 397.33K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.